Determinants of exacerbation risk in patients with COPD in the TIOSPIR study
Peter MA Calverley,1 Kay Tetzlaff,2 Daniel Dusser,3 Robert A Wise,4 Achim Mueller,5 Norbert Metzdorf,2 Antonio Anzueto6 1Clinical Science Centre, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK; 2Respiratory Medicine, Boehringer Ingelheim Pharma GmbH, Ingelheim am Rh...
Main Authors: | Calverley PMA, Tetzlaff K, Dusser D, Wise RA, Mueller A, Metzdorf N, Anzueto A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-11-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/determinants-of-exacerbation-risk-in-patients-with-copd-in-the-tiospir-peer-reviewed-article-COPD |
Similar Items
-
Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD
by: Calverley PMA, et al.
Published: (2018-04-01) -
The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype
by: Miłkowska-Dymanowska J, et al.
Published: (2018-11-01) -
Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization
by: Dilektasli AG, et al.
Published: (2017-01-01) -
Neutrophil-to-Lymphocyte Ratio Predicts Clinical Outcome of Severe Acute Exacerbation of COPD in Frequent Exacerbators
by: Lu FY, et al.
Published: (2021-02-01) -
Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR® trial
by: Wise RA, et al.
Published: (2018-02-01)